The Micro Cap Opportunity

The Micro Cap Opportunity has Re-Initiated Coverage on an Lantis Laser after Monday's close!

Lantis Laser Inc.
(OTC: LLSR)
Monday, June 9th, 2008

Our newest 'Featured Pick' happens to be one of our favorite picks of the last year, Lantis Laser Inc. (OTC: LLSR) . With some very important developments released by the Company in the last week, we think its an easy double from here!

Investment Considerations:

• Antiquated Technologies in Desperate Need of an “Upgrade”: Dental industry (100,000+ offices in North America) still using diagnotstic technologies stuck in the “dark ages” - X-ray based technology first developed in the 1800’s.

• Medical Research Suggests that Oral Health and General Health are Inextricably Linked: The medical establishment almost universally agrees that poor dental health is a precursor to more serious general health diseases including heart disease.

• Next-Generation Technology Promises Earlier and More Accurate Detection of Periodontal Disease: Lanti’s Optical Coherence Tomography (OCT) enable painless imaging of soft tissue (gums) and teeth on a detailed scale never before seen.
  

• Patented, Defensable Positioning until 2020 = No Competition in Sight: OCT technology was developed by MIT and prestigious Lawrence Livermore National Laboratories. Lantis Laser has exclusive worldwide rights for application to the field for Dentistry for next 12 years.

• OCT Already Proven, FDA Approved For Medical Applications & Has Generated Hundreds of Millions of Dollars in Revenues: FDA approved OCT for Cardiovascular medicine, Optometry and Urology. Carl Zeiss Meditec AG has already generated over $400 Million in worldwide sales of OCT applications in these fields.

• New Strategic Supply Agreement With OCT Equipment Leader: Lantis just announced exclusive multi-year, multi million dollar supply agreement with the pre-eminent OCT equipment manufacturer assuring scaled and low cost equipment production.

• ‘Reasonable’ $20.6 Million current Market Capitalization makes for a compelling risk vs. reward scenario.   

CLICK HERE to read our coverage

OUR PICK: LLSR.PK
OUR RATING: Speculative Buy & Trade
ALERT PRICE: $.21
SHORT-TERM TARGET': $.45 (114%+ Return Potential)

Warm Wishes & Happy Trading,

~MCO Staff

P.S. Make sure you read our disclaimer on the Disclaimer Section of our website.